196 related articles for article (PubMed ID: 33550515)
1. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
4. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
Alberts I; Hünermund JN; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Vollnberg B; Shi K; Afshar-Oromieh A; Rominger A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2395-2404. PubMed ID: 33797596
[TBL] [Abstract][Full Text] [Related]
5. Image Quality and Activity Optimization in Oncologic
van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
[TBL] [Abstract][Full Text] [Related]
6. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
9. Are lesion features reproducible between
Constantino CS; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz SC; Vieira P; Costa DC
Eur Radiol; 2021 May; 31(5):3071-3079. PubMed ID: 33125562
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
11. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
13. Reduced count pediatric whole-body
Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
[TBL] [Abstract][Full Text] [Related]
14. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
[TBL] [Abstract][Full Text] [Related]
15. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of
Weber M; Jentzen W; Hofferber R; Herrmann K; Fendler WP; Rischpler C; Umutlu L; Conti M; Costa PF; Sraieb M; Kersting D
BMC Cancer; 2021 Jan; 21(1):62. PubMed ID: 33446147
[TBL] [Abstract][Full Text] [Related]
17. The image quality, lesion detectability, and acquisition time of
Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of total-body
Hu Y; Liu G; Yu H; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
[TBL] [Abstract][Full Text] [Related]
19. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of equivalent performance of 3D TOF [
Pilz J; Hehenwarter L; Zimmermann G; Rendl G; Schweighofer-Zwink G; Beheshti M; Pirich C
EJNMMI Res; 2021 May; 11(1):44. PubMed ID: 33934218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
